{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreigcr53r4rjmzisx7htwwkmtasq22oqrobiyr4edy6gzmxdtn4qowa",
    "uri": "at://did:plc:yhmwewfk3g3hhkrw2gf4ypna/app.bsky.feed.post/3mpiccfdtg7s2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreihjbovbzltzhqz45f6ct7hvsljxt6y6l2sgthpxnkvgw727ppndim"
    },
    "mimeType": "image/jpeg",
    "size": 35064
  },
  "path": "/2026/06/29/niacinamide-cancer/",
  "publishedAt": "2026-06-30T03:33:32.000Z",
  "site": "https://dissentwatch.com",
  "tags": [
    "#Column1"
  ],
  "textContent": "STORY AT-A-GLANCE Glioblastoma is considered one of the most aggressive brain cancers, with survival often limited to about a year, largely because tumors adapt by rewiring how they use nutrients and energy Tumors divert vitamin B3 (niacinamide) away from normal energy production into a pathway that supports their survival, suggesting a metabolic weakness that could […]",
  "title": "What Niacinamide Studies May Reveal About Cancer as a Metabolic Disease"
}